Why did Amgen, the first EA in Pharma decide to go EA? There was expected value around having unlimited tags and a standard infrastructure. There would be no tag counting and best practices from one facility could be utilized across all facilities giving an overall lower total cost of ownership. What were the hurdles and requirements for a regulated industry for EA? What were the unexpected benefits? What is the benefit and role of the Center of Excellence? What changes did Amgen have to do internally to take advantage of the EA?
Speaker
Robert Gamber
Rob Gamber has been working in the automated manufacturing space since graduating from the University of Colorado in 1993 with a BS in Mechanical Engineering. He has held various roles in Engineering and Information systems during his tenure at Amgen, including managing a group of Business Analysts supporting the manufacturing, supply chain, facilities, quality analytical laboratories, and process development functional groups at the Colorado site. Rob was the IS Lead in implementing PI for the Colorado site, pioneering the development of the module database and batch related functions within Amgen. Rob earned his MBA from Colorado State University in 2004, and has subsequently moved into a corporate IS role as Platform Lead for manufacturing data systems.